Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.H.S., Duke University 2013
  • Pharm.D., Purdue University 1988
• 

  Duke Appointment History

  • Associate Professor in Medicine, Medicine, Clinical Pharmacology, Medicine 2008 - 2015
  • Associate Professor in Medicine, Medicine, Clinical Pharmacology, Medicine 2006 - 2008
  • Associate Clinical Professor in Medicine, Medicine, Clinical Pharmacology, Medicine 2004 - 2006
• Research
• 

  Selected Grants

  • Educational Videos to Reduce Racial Disparities in ICD therapy Via Innovative Designs (VIVID) awarded by Patient Centered Outcomes Research Institute 2016 - 2021
  • Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health 2011 - 2020
  • Value of Information Analysis: PCORnet Aspirin Maintenance Doseage Trial awarded by Patient Centered Outcomes Research Institute 2015 - 2016
  • Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health 2007 - 2015
  • Duke Cardiovascular CERTs awarded by Agency for Healthcare Research and Quality 2007 - 2012
  • Improving Quality through Decision Support for Evidence-Based Pharmacotherapy awarded by Agency for Healthcare Research and Quality 2007 - 2011
  • EPC_TO#3_WA#7_Anemia Management in Renal Disease Populations - Part 2 awarded by Agency for Healthcare Research and Quality 2010
  • EPC _TO #1_WA #3_Anemia Management in Renal Disease Populations - (Part 1) awarded by Agency for Healthcare Research and Quality 2010
  • Safer Antithrombotic Therapy for Elderly ACS Patients awarded by National Institutes of Health 2005 - 2008
  • DCRI Research Center for CERTs awarded by Agency for Healthcare Research and Quality 1999 - 2008
  • DCRI CERT for Cardiovascular Therapies awarded by National Institutes of Health 1999 - 2002
• 

  External Relationships

  • Premier, Inc
• Publications & Artistic Works
• 

  Selected Publications

  • Academic Articles

    • Thomas, Kevin L., Lonnie T. Sullivan, Sana M. Al-Khatib, Nancy Allen LaPointe, Sam Sears, Andrzej S. Kosinski, Larry R. Jackson, Valentina Kutyifa, and Eric D. Peterson. “Videos to reduce racial disparities in ICD therapy Via Innovative Designs (VIVID) trial: Rational, design and methodology.” Am Heart J 220 (February 2020): 59–67. https://doi.org/10.1016/j.ahj.2019.10.011.
       Full Text  Link to Item
    • Lowenstern, Angela, Sana M. Al-Khatib, Lauren Sharan, Ranee Chatterjee, Nancy M. Allen LaPointe, Bimal Shah, Ethan D. Borre, et al. “Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review.” Ann Intern Med 169, no. 11 (December 4, 2018): 774–87. https://doi.org/10.7326/M18-1523.
       Full Text  Link to Item
    • Borre, Ethan D., Adam Goode, Giselle Raitz, Bimal Shah, Angela Lowenstern, Ranee Chatterjee, Lauren Sharan, et al. “Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review.” Thromb Haemost 118, no. 12 (December 2018): 2171–87. https://doi.org/10.1055/s-0038-1675400.
       Full Text  Link to Item
    • Hess, Connie N., R Kevin Rogers, Tracy Y. Wang, Rao Fu, Jacob Gundrum, Nancy M. Allen LaPointe, and William R. Hiatt. “Major Adverse Limb Events and 1-Year Outcomes After Peripheral Artery Revascularization.” J Am Coll Cardiol 72, no. 9 (August 28, 2018): 999–1011. https://doi.org/10.1016/j.jacc.2018.06.041.
       Full Text  Link to Item
    • Goode, Adam P., Remy R. Coeytaux, Gary R. Maslow, Naomi Davis, Sherika Hill, Behrouz Namdari, Nancy M Allen LaPointe, et al. “Nonpharmacologic Treatments for Attention-Deficit/Hyperactivity Disorder: A Systematic Review.” Pediatrics 141, no. 6 (June 2018). https://doi.org/10.1542/peds.2018-0094.
       Full Text  Link to Item
    • Pokorney, Sean D., Debbie C. Yen, Kristen B. Campbell, Nancy M. Allen LaPointe, Shubin Sheng, Laine Thomas, Tristram D. Bahnson, et al. “Dofetilide dose reductions and discontinuations in women compared with men.” Heart Rhythm 15, no. 4 (April 2018): 478–84. https://doi.org/10.1016/j.hrthm.2018.01.027.
       Full Text  Link to Item
    • Anderson, Monique L., Rachel Peragallo Urrutia, Emily C. O’Brien, Nancy M. Allen LaPointe, Alexander J. Christian, Lisa A. Kaltenbach, Laura E. Webb, et al. “Outcomes of a multi-community hypertension implementation study: the American Heart Association's Check. Change. Control. program.” J Clin Hypertens (Greenwich) 19, no. 5 (May 2017): 479–87. https://doi.org/10.1111/jch.12950.
       Full Text  Link to Item
    • Pokorney, Sean D., Xiaojuan Mi, Bradley G. Hammill, Nancy M. Allen LaPointe, Lesley H. Curtis, and Sana M. Al-Khatib. “Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia.” Am J Cardiol 119, no. 9 (May 1, 2017): 1401–6. https://doi.org/10.1016/j.amjcard.2017.01.030.
       Full Text  Link to Item
    • Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Nancy Allen LaPointe, Alex Cho, and Geoffrey S. Ginsburg. “Primary care providers' use of pharmacist support for delivery of pharmacogenetic testing.” Pharmacogenomics 18, no. 4 (March 2017): 359–67. https://doi.org/10.2217/pgs-2016-0177.
       Full Text
    • Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Nancy Allen Lapointe, Alex Cho, and Geoffrey S. Ginsburg. “Patient experiences with pharmacogenetic testing in a primary care setting.” Pharmacogenomics 17, no. 15 (October 2016): 1629–36. https://doi.org/10.2217/pgs-2016-0077.
       Full Text  Link to Item
    • Duan-Porter, Wei, Karen M. Goldstein, Jennifer R. McDuffie, Jaime M. Hughes, Megan E. B. Clowse, Ruth S. Klap, Varsha Masilamani, et al. “Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic Pain.” Ann Intern Med 165, no. 3 (August 2, 2016): 184–93. https://doi.org/10.7326/M15-2877.
       Full Text  Link to Item
    • Haga, Susanne B., Jivan Moaddeb, Rachel Mills, Mahesh Patel, William Kraus, and Nancy M. Allen LaPointe. “Incorporation of pharmacogenetic testing into medication therapy management.” Pharmacogenomics 16, no. 17 (November 10, 2015): 1931–41. https://doi.org/10.2217/pgs.15.124.
       Full Text
    • Allen LaPointe, Nancy M., David Dai, Laine Thomas, Jonathan P. Piccini, Eric D. Peterson, and Sana M. Al-Khatib. “Comparisons of hospitalization rates among younger atrial fibrillation patients receiving different antiarrhythmic drugs.” Circ Cardiovasc Qual Outcomes 8, no. 3 (May 2015): 292–300. https://doi.org/10.1161/CIRCOUTCOMES.114.001499.
       Full Text  Link to Item
    • Haga, Susanne B., Nancy M. Allen LaPointe, and Jivan Moaddeb. “Challenges to integrating pharmacogenetic testing into medication therapy management.” J Manag Care Spec Pharm 21, no. 4 (April 2015): 346–52. https://doi.org/10.18553/jmcp.2015.21.4.346.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Dadi Dai, Laine Thomas, Jonathan P. Piccini, Eric D. Peterson, and Sana M. Al-Khatib. “Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease.” Am J Cardiol 115, no. 3 (February 1, 2015): 316–22. https://doi.org/10.1016/j.amjcard.2014.11.005.
       Full Text  Link to Item
    • Kuntz, Jennifer L., Monika M. Safford, Jasvinder A. Singh, Shobha Phansalkar, Sarah P. Slight, Qoua Liang Her, Nancy Allen Lapointe, et al. “Patient-centered interventions to improve medication management and adherence: a qualitative review of research findings.” Patient Educ Couns 97, no. 3 (December 2014): 310–26. https://doi.org/10.1016/j.pec.2014.08.021.
       Full Text  Link to Item
    • Haga, Susanne B., Nancy M. Allen LaPointe, Jivan Moaddeb, Rachel Mills, Mahesh Patel, and William E. Kraus. “Pilot study: incorporation of pharmacogenetic testing in medication therapy management services.” Pharmacogenomics 15, no. 14 (November 2014): 1729–37. https://doi.org/10.2217/pgs.14.118.
       Full Text  Link to Item
    • Thomas, Kevin L., Bimal R. Shah, Sharon Elliot-Bynum, Kristin D. Thomas, Katrina Damon, Nancy M. Allen LaPointe, Sarah Calhoun, et al. “Check it, change it: a community-based, multifaceted intervention to improve blood pressure control.” Circ Cardiovasc Qual Outcomes 7, no. 6 (November 2014): 828–34. https://doi.org/10.1161/CIRCOUTCOMES.114.001039.
       Full Text  Link to Item
    • Haga, Susanne B., Nancy M Allen LaPointe, Alex Cho, Shelby D. Reed, Rachel Mills, Jivan Moaddeb, and Geoffrey S. Ginsburg. “Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.” Pharmacogenomics 15, no. 13 (September 2014): 1677–86. https://doi.org/10.2217/pgs.14.109.
       Full Text  Link to Item
    • Piccini, Jonathan P., Sana M. Al-Khatib, Daniel M. Wojdyla, Linda K. Shaw, John R. Horton, Yuliya Lokhnygina, Kevin J. Anstrom, et al. “Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.” Am J Cardiol 114, no. 5 (September 1, 2014): 716–22. https://doi.org/10.1016/j.amjcard.2014.06.004.
       Full Text  Link to Item
    • Al-Khatib, Sana M., Nancy M. Allen LaPointe, Ranee Chatterjee, Matthew J. Crowley, Matthew E. Dupre, David F. Kong, Renato D. Lopes, et al. “Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic review.” Ann Intern Med 160, no. 11 (June 3, 2014): 760–73. https://doi.org/10.7326/M13-1467.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Yuliya Lokhnygina, Jacqueline Rimmler, Gillian D. Sanders, Eric D. Peterson, and Sana M. Al-Khatib. “Use Of Rate And Rhythm Control Drugs In Patients Younger Than 65 Years With Atrial Fibrillation.” J Atr Fibrillation 7, no. 1 (2014): 22–30.
       Link to Item
    • Haga, S. B., and N. M. A. LaPointe. “The potential impact of pharmacogenetic testing on medication adherence.” Pharmacogenomics J 13, no. 6 (December 2013): 481–83. https://doi.org/10.1038/tpj.2013.33.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Yuliya Lokhnygina, Gillian D. Sanders, Eric D. Peterson, and Sana M. Al-Khatib. “Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation.” Am Heart J 166, no. 5 (November 2013): 871–78. https://doi.org/10.1016/j.ahj.2013.08.010.
       Full Text  Link to Item
    • Shah, Bimal R., Kevin L. Thomas, Sharon Elliot-Bynum, Kristin Thomas, Katrina Damon, Nancy Allen LaPointe, Sarah A. Calhoun, et al. “Check it, change it: a community-based intervention to improve blood pressure control.” Circ Cardiovasc Qual Outcomes 6, no. 6 (November 2013): 741–48. https://doi.org/10.1161/CIRCOUTCOMES.113.000148.
       Full Text  Link to Item
    • Thomas, Kevin L., Louise O. Zimmer, David Dai, Sana M. Al-Khatib, Nancy M. Allen LaPointe, and Eric D. Peterson. “Educational videos to reduce racial disparities in ICD therapy via innovative designs (VIVID): a randomized clinical trial.” Am Heart J 166, no. 1 (July 2013): 157–63. https://doi.org/10.1016/j.ahj.2013.03.031.
       Full Text  Link to Item
    • Willis, Janese M., Rex Edwards, Kevin J. Anstrom, Fred S. Johnson, Guilherme Del Fiol, Kensaku Kawamoto, Nancy M Allen Lapointe, Eric L. Eisenstein, and David F. Lobach. “Decision support for evidence-based pharmacotherapy detects adherence problems but does not impact medication use.” Stud Health Technol Inform 183 (2013): 116–25.
       Link to Item
    • Thomas, Kevin L., Bimal R. Shah, Sharon Elliott-Bynum, Kristin D. Thomas, Katrina Damon, Nancy Allen Lapointe, Sarah Calhoun, et al. “Check It Change It: A Community Based Hypertension Program.” Circulation 126, no. 21 (November 20, 2012).
       Link to Item
    • American College of Clinical Pharmacy, Barbara, Anne L. Hume, Jennifer Kirwin, Heather L. Bieber, Rachel L. Couchenour, Deanne L. Hall, Amy K. Kennedy, et al. “Improving care transitions: current practice and future opportunities for pharmacists.” Pharmacotherapy 32, no. 11 (November 2012): e326–37. https://doi.org/10.1002/phar.1215.
       Full Text  Link to Item
    • Atwater, Brett D., David Dai, Nancy M. Allen-Lapointe, Sana M. Al-Khatib, Louise O. Zimmer, Gillian D. Sanders, and Eric D. Peterson. “Is heart failure guideline adherence being underestimated? The impact of therapeutic contraindications.” Am Heart J 164, no. 5 (November 2012): 750-755.e1. https://doi.org/10.1016/j.ahj.2012.08.002.
       Full Text  Link to Item
    • Calvert, Sara Bristol, Judith M. Kramer, Kevin J. Anstrom, Lisa A. Kaltenbach, Judith A. Stafford, and Nancy M. Allen LaPointe. “Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial.” Am Heart J 163, no. 4 (April 2012): 657-65.e1. https://doi.org/10.1016/j.ahj.2012.01.019.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Fang-Shu Ou, Sara B. Calvert, Chiara Melloni, Judith A. Stafford, Tina Harding, Eric D. Peterson, and Karen P. Alexander. “Association between patient beliefs and medication adherence following hospitalization for acute coronary syndrome.” Am Heart J 161, no. 5 (May 2011): 855–63. https://doi.org/10.1016/j.ahj.2011.02.009.
       Full Text  Link to Item
    • LaPointe, Nancy M Allen, Sana M. Al-Khatib, Jonathan P. Piccini, Brett D. Atwater, Emily Honeycutt, Kevin Thomas, Bimal R. Shah, Louise O. Zimmer, Gillian Sanders, and Eric D. Peterson. “Extent of and reasons for nonuse of implantable cardioverter defibrillator devices in clinical practice among eligible patients with left ventricular systolic dysfunction.” Circ Cardiovasc Qual Outcomes 4, no. 2 (March 2011): 146–51. https://doi.org/10.1161/CIRCOUTCOMES.110.958603.
       Full Text  Link to Item
    • Del Fiol, Guilherme, Kensaku Kawamoto, Nancy M Allen Lapointe, Eric L. Eisenstein, Kevin J. Anstrom, Laura L. Wood, and David F. Lobach. “Improving Medication Adherence in a Regional Healthcare Information Exchange using a Scalable, Claims-Driven, and Service-Oriented Approach.” Amia Annu Symp Proc 2010 (November 13, 2010): 137–41.
       Link to Item
    • Allen LaPointe, Nancy M., Fang-Shu Ou, Sara B. Calvert, Chiara Melloni, Judith A. Stafford, Tina Harding, Karen P. Alexander, and Eric D. Peterson. “Changes in beliefs about medications during long-term care for ischemic heart disease.” Am Heart J 159, no. 4 (April 2010): 561–69. https://doi.org/10.1016/j.ahj.2009.12.025.
       Full Text  Link to Item
    • LaPointe, Nancy M Allen, Jie-Lena Sun, and Sigal Kaplan. “In-hospital management of patients with atrial flutter.” Am Heart J 159, no. 3 (March 2010): 370–76. https://doi.org/10.1016/j.ahj.2009.12.013.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Anita Y. Chen, Matthew T. Roe, David J. Cohen, Deborah B. Diercks, James W. Hoekstra, Francis M. Fesmire, W Brian Gibler, E Magnus Ohman, and Eric D. Peterson. “Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome.” Am J Cardiol 104, no. 10 (November 15, 2009): 1324–29. https://doi.org/10.1016/j.amjcard.2009.06.054.
       Full Text  Link to Item
    • Melloni, Chiara, Karen P. Alexander, Fang-Shu Ou, Nancy M Allen LaPointe, Matthew T. Roe, L Kristin Newby, Khaula Baloch, P Michael Ho, John S. Rumsfeld, and Eric D. Peterson. “Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome.” Am J Cardiol 104, no. 2 (July 15, 2009): 175–81. https://doi.org/10.1016/j.amjcard.2009.03.013.
       Full Text  Link to Item
    • LaPointe, Nancy M Allen, Judith A. Stafford, Paul A. Pappas, Sana M. Al-Khatib, and Kevin J. Anstrom. “Use of beta-blockers in patients with an implantable cardioverter defibrillator.” Ann Pharmacother 43, no. 7 (July 2009): 1189–96. https://doi.org/10.1345/aph.1M140.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Yi Zhou, Judith A. Stafford, Adrian F. Hernandez, Judith M. Kramer, and Kevin J. Anstrom. “Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease.” Am J Cardiol 103, no. 11 (June 1, 2009): 1518–24. https://doi.org/10.1016/j.amjcard.2009.01.363.
       Full Text  Link to Item
    • Melloni, Chiara, Karen P. Alexander, Anita Y. Chen, L Kristin Newby, Matthew T. Roe, Nancy M. Allen LaPointe, Charles V. Pollack, et al. “Unfractionated heparin dosing and risk of major bleeding in non-ST-segment elevation acute coronary syndromes.” Am Heart J 156, no. 2 (August 2008): 209–15. https://doi.org/10.1016/j.ahj.2008.03.023.
       Full Text  Link to Item
    • Alexander, Karen P., Anita Y. Chen, Tracy Y. Wang, Sunil V. Rao, L Kristin Newby, Nancy M Allen LaPointe, E Magnus Ohman, et al. “Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes.” Am Heart J 155, no. 6 (June 2008): 1047–53. https://doi.org/10.1016/j.ahj.2008.01.009.
       Full Text  Link to Item
    • Allen Lapointe, Nancy M., Jie-Lena Sun, Sigal Kaplan, Phil d’Almada, and Sana M. Al-Khatib. “Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.” Am J Cardiol 101, no. 8 (April 15, 2008): 1134–41. https://doi.org/10.1016/j.amjcard.2007.11.067.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Laura Governale, Jerry Watkins, Jyotsna Mulgund, and Kevin J. Anstrom. “Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.” Am Heart J 154, no. 5 (November 2007): 893–98. https://doi.org/10.1016/j.ahj.2007.06.035.
       Full Text  Link to Item
    • Kawamoto, Kensaku, Nancy M. Allen LaPointe, Garry M. Silvey, Kevin J. Anstrom, Eric L. Eisenstein, and David F. Lobach. “Development and evaluation of an improved methodology for assessing adherence to evidence-based drug therapy guidelines using claims data.” Amia Annu Symp Proc, October 11, 2007, 394–98.
       Link to Item
    • Swanson, J., and M. Swartz. “Authors' reply [4].” British Journal of Psychiatry 191, no. OCT. (October 1, 2007): 358–59. https://doi.org/10.1192/bjp.191.4.358a.
       Full Text
    • LaPointe, Nancy M Allen, Anita Y. Chen, Karen P. Alexander, Matthew T. Roe, Charles V. Pollack, Barbara L. Lytle, Magnus E. Ohman, Brian W. Gibler, and Eric D. Peterson. “Enoxaparin dosing and associated risk of in-hospital bleeding and death in patients with non ST-segment elevation acute coronary syndromes.” Arch Intern Med 167, no. 14 (July 23, 2007): 1539–44. https://doi.org/10.1001/archinte.167.14.1539.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Paul Pappas, Patricia Deverka, and Kevin J. Anstrom. “Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions.” J Gen Intern Med 22, no. 1 (January 2007): 98–101. https://doi.org/10.1007/s11606-007-0109-4.
       Full Text  Link to Item
    • Kramer, Judith M., Bradley Hammill, Kevin J. Anstrom, Donald Fetterolf, Richard Snyder, John P. Charde, Barbara S. Hoffman, Nancy Allen LaPointe, and Eric Peterson. “National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance.” Am Heart J 152, no. 3 (September 2006): 454.e1-454.e8. https://doi.org/10.1016/j.ahj.2006.02.030.
       Full Text  Link to Item
    • Newby, L. K., N. M. Allen-LaPointe, A. Y. Chen, J. M. Kramer, B. G. Hammill, E. R. DeLong, L. H. Muhlbaier, and R. M. Califf. “Response to letter regarding article, "Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease" [2].” Circulation 114, no. 6 (August 1, 2006). https://doi.org/10.1161/CIRCULATIONAHA.106.627521.
       Full Text
    • Allen LaPointe, Nancy M., Lesley H. Curtis, K Arnold Chan, Judith M. Kramer, Jennifer Elston Lafata, Jerry H. Gurwitz, Marsha A. Raebel, and Richard Platt. “Frequency of high-risk use of QT-prolonging medications.” Pharmacoepidemiol Drug Saf 15, no. 6 (June 2006): 361–68. https://doi.org/10.1002/pds.1155.
       Full Text  Link to Item
    • Allen LaPointe, N. M., E. R. DeLong, A. Chen, B. G. Hammill, L. H. Muhlbaier, R. M. Califf, and J. M. Kramer. “Multifaceted intervention to promote β-blocker use in heart failure.” American Heart Journal 151, no. 5 (May 1, 2006): 999–1005. https://doi.org/10.1016/j.ahj.2005.10.011.
       Full Text
    • LaPointe, Nancy M Allen, Elizabeth R. DeLong, Anita Chen, Bradley G. Hammill, Lawrence H. Muhlbaier, Robert M. Califf, and Judith M. Kramer. “Multifaceted intervention to promote beta-blocker use in heart failure.” Am Heart J 151, no. 5 (May 2006): 992–98. https://doi.org/10.1016/j.ahj.2005.06.038.
       Full Text  Link to Item
    • Newby, L Kristin, Nancy M Allen LaPointe, Anita Y. Chen, Judith M. Kramer, Bradley G. Hammill, Elizabeth R. DeLong, Lawrence H. Muhlbaier, and Robert M. Califf. “Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease.” Circulation 113, no. 2 (January 17, 2006): 203–12. https://doi.org/10.1161/CIRCULATIONAHA.105.505636.
       Full Text  Link to Item
    • LaPointe, N. M. A., and J. M. Kramer. “Authors' reply.” American Heart Journal 152, no. 4 (2006): e45. https://doi.org/10.1016/j.ahj.2006.07.006.
       Full Text
    • Alexander, Karen P., Anita Y. Chen, Matthew T. Roe, L Kristin Newby, C Michael Gibson, Nancy M. Allen-LaPointe, Charles Pollack, et al. “Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.” Jama 294, no. 24 (December 28, 2005): 3108–16. https://doi.org/10.1001/jama.294.24.3108.
       Full Text  Link to Item
    • Al-Khatib, Sana M., Nancy M. Allen LaPointe, Judith M. Kramer, Anita Y. Chen, Bradley G. Hammill, Liz Delong, and Robert M. Califf. “A survey of health care practitioners' knowledge of the QT interval.” J Gen Intern Med 20, no. 5 (May 2005): 392–96. https://doi.org/10.1111/j.1525-1497.2005.0101.x.
       Full Text  Link to Item
    • Cowper, Patricia A., Elizabeth R. DeLong, David J. Whellan, Nancy M. Allen LaPointe, and Robert M. Califf. “Economic effects of beta-blocker therapy in patients with heart failure.” Am J Med 116, no. 2 (January 15, 2004): 104–11. https://doi.org/10.1016/j.amjmed.2003.07.016.
       Full Text  Link to Item
    • Newby, L Kristin, Manjushri V. Bhapkar, Harvey D. White, David J. Moliterno, Nancy M Allen LaPointe, David E. Kandzari, Freek W. A. Verheugt, et al. “Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.” J Thromb Thrombolysis 16, no. 3 (December 2003): 119–28. https://doi.org/10.1023/B:THRO.0000024050.78728.35.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Anita Chen, Bradley Hammill, Elizabeth DeLong, Judith M. Kramer, and Robert M. Califf. “Evaluation of the dofetilide risk-management program.” Am Heart J 146, no. 5 (November 2003): 894–901. https://doi.org/10.1016/S0002-8703(03)00409-5.
       Full Text  Link to Item
    • LaPointe, Nancy M Allen, Carol A. Pamer, and Judith M. Kramer. “New antiarrhythmic agents for atrial fibrillation and atrial flutter: United States drug market response as an indicator of acceptance.” Pharmacotherapy 23, no. 10 (October 2003): 1316–21. https://doi.org/10.1592/phco.23.12.1316.32703.
       Full Text  Link to Item
    • Krantz, Mori J., Bridget A. Martell, Julia H. Arnsten, and Marc N. Gourevitch. “Medications that prolong the QT interval.” Jama 290, no. 8 (August 27, 2003): 1025. https://doi.org/10.1001/jama.290.8.1025-a.
       Full Text  Link to Item
    • LaPointe, Nancy M Allen, and James G. Jollis. “Medication errors in hospitalized cardiovascular patients.” Arch Intern Med 163, no. 12 (June 23, 2003): 1461–66. https://doi.org/10.1001/archinte.163.12.1461.
       Full Text  Link to Item
    • Al-Khatib, Sana M., Nancy M Allen LaPointe, Judith M. Kramer, and Robert M. Califf. “What clinicians should know about the QT interval.” Jama 289, no. 16 (April 23, 2003): 2120–27. https://doi.org/10.1001/jama.289.16.2120.
       Full Text  Link to Item
    • LaPointe, Nancy M Allen, Sana M. Al-Khatib, Judith M. Kramer, and Robert M. Califf. “Knowledge deficits related to the QT interval could affect patient safety.” Ann Noninvasive Electrocardiol 8, no. 2 (April 2003): 157–60. https://doi.org/10.1046/j.1542-474x.2003.08211.x.
       Full Text  Link to Item
    • Curtis, Lesley H., Truls Østbye, Veronica Sendersky, Steve Hutchison, Nancy M. Allen LaPointe, Sana M. Al-Khatib, Sally Usdin Yasuda, et al. “Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.” Am J Med 114, no. 2 (February 1, 2003): 135–41. https://doi.org/10.1016/s0002-9343(02)01455-9.
       Full Text  Link to Item
    • Al-Khatib, Sana M., Nancy M Allen LaPointe, Lesley H. Curtis, Judith M. Kramer, Joslyn Swann, Peter Honig, and Robert M. Califf. “Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000.” Am J Cardiol 91, no. 1 (January 1, 2003): 91–94. https://doi.org/10.1016/s0002-9149(02)03008-4.
       Full Text  Link to Item
    • LaPointe, Nancy M Allen, Judith M. Kramer, Kevin P. Weinfurt, and Robert M. Califf. “Practitioner acceptance of the dofetilide risk-management program.” Pharmacotherapy 22, no. 8 (August 2002): 1041–46. https://doi.org/10.1592/phco.22.12.1041.33611.
       Full Text  Link to Item
    • Allen LaPointe, Nancy M., Judith M. Kramer, Elizabeth R. DeLong, Truls Ostbye, Bradley G. Hammill, Lawrence H. Muhlbaier, Charles B. McCants, Anita Chen, and Robert M. Califf. “Patient-reported frequency of taking aspirin in a population with coronary artery disease.” Am J Cardiol 89, no. 9 (May 1, 2002): 1042–46. https://doi.org/10.1016/s0002-9149(02)02272-5.
       Full Text  Link to Item
    • Califf, Robert M., Elizabeth R. DeLong, Truls Ostbye, Lawrence H. Muhlbaier, Anita Chen, Nancy Allen LaPointe, Bradley G. Hammill, Charles B. McCants, and Judith M. Kramer. “Underuse of aspirin in a referral population with documented coronary artery disease.” Am J Cardiol 89, no. 6 (March 15, 2002): 653–61. https://doi.org/10.1016/s0002-9149(01)02335-9.
       Full Text  Link to Item
    • Allen LaPointe, N. M., and P. Li. “Continuous intravenous quinidine infusion for the treatment of atrial fibrillation or flutter: a case series.” Am Heart J 139, no. 1 Pt 1 (January 2000): 114–21. https://doi.org/10.1016/s0002-8703(00)90317-x.
       Full Text  Link to Item
    • Williamson, K. M., K. A. Thrasher, K. B. Fulton, N. M. LaPointe, G. D. Dunham, A. A. Cooper, P. S. Barrett, and J. H. Patterson. “Digoxin toxicity: an evaluation in current clinical practice.” Arch Intern Med 158, no. 22 (December 7, 1998): 2444–49. https://doi.org/10.1001/archinte.158.22.2444.
       Full Text  Link to Item
    • Allen, N. M., and R. L. Page. “Procainamide administration during pregnancy.” Clin Pharm 12, no. 1 (January 1993): 58–60.
       Link to Item
    • Allen, N. M. “Relationship between serum quinidine concentration and quinidine dosage.” Pharmacotherapy 12, no. 3 (1992): 189–94.
       Link to Item
    • Allen, N. M., G. D. Dunham, J. M. Sailstad, and J. W. Findlay. “Clinical and pharmacokinetic profiles of digoxin immune Fab in four patients with renal impairment.” Dicp 25, no. 12 (December 1991): 1315–20. https://doi.org/10.1177/106002809102501205.
       Full Text  Link to Item
    • Allen, N. M. “Retreatment with digoxin immune Fab.” Clin Pharm 10, no. 11 (November 1991): 823–24.
       Link to Item
    • Allen, N. M., and G. D. Dunham. “Treatment of digitalis intoxication with emphasis on the clinical use of digoxin immune Fab.” Dicp 24, no. 10 (October 1990): 991–98. https://doi.org/10.1177/106002809002401015.
       Full Text  Link to Item
    • Kemper, Alex R., Gary R. Maslow, Sherika Hill, Behrouz Namdari, Nancy M. Allen LaPointe, Adam P. Goode, Remy R. Coeytaux, et al. “Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents,” n.d. https://doi.org/10.23970/ahrqepccer203.
       Full Text

  • Book Sections

    • Willis JM, S. J., R. Edwards, K. J. Anstrom, F. S. Johnson, G. Del Fiol, K. Kawamoto, N. M. Allen lapointe, E. L. Eisenstein, and D. F. Lobach. “Decision Support for Evidence-Based Pharmacotherapy Detects Adherence Problems but Does Not Impact Medication Use.” In Enabling Health and Healthcare Through ICT, edited by Karen L. Courtney, Omid Shabestari, and Alexander Kuo, 183:116–25. IOS Press, 2013.
    • Allen LaPointe, N. M. “Pharmacoepidemiology And Therapeutic Risk Management.” In Pharmacoepidemiology And Therapeutic Risk Management, edited by Abraham G. Hartzema. Harvey Whitney Books Company, 2008.
    • Allen LaPointe, N. M. “Pharmacoepidemiology And Therapeutic Risk Management.” In Pharmacoepidemiology And Therapeutic Risk Management, edited by Abraham G. Hartzema. Harvey Whitney Books Company, 2008.

  • Reports

    • Al-Khatib, S. M., N. Allen LaPointe, R. Chatterjee, M. J. Crowley, M. E. Dupre, D. F. Kong, R. D. Lopes, et al. “Treatment of Atrial Fibrillation. Comparative Effectiveness Review 119.” Treatment of Atrial Fibrillation. Comparative Effectiveness Review 119. Rockville, MD: AHRQ Publication, June 28, 2013.
    • DOLOR, R. J., C. Melloni, R. Chatterjee, N. Allen Lapointe, J. B. williams, R. R. Coeytaux, A. J. McBroom, et al. “Treatment Strategies for Women With Coronary Artery Disease.” Comparative Effectiveness Reviews, No. 66, August 1, 2012.

  • Conference Papers

    • Hess, Connie Ng, Julia Weleski Fu, Jacob Gundrum, Nancy Allen LaPointe, Tracy Wang, Kevin Rogers, William R. Hiatt, and Marc P. Bonaca. “RISK AND COSTS AFTER PERIPHERAL REVASCULARIZATION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE WITH AND WITHOUT DIABETES.” In Journal of the American College of Cardiology, 75:1303–1303. ELSEVIER SCIENCE INC, 2020.
       Link to Item
    • Hess, Connie N., Tracy Y. Wang, Julia Weleski Fu, Jacob Gundrum, Nancy Allen LaPointe, Robert K. Rogers, and William R. Hiatt. “Long-term Cardiovascular and Limb Outcomes and Associations With Major Adverse Limb Events After Peripheral Revascularization.” In Circulation, Vol. 140, 2019.
       Link to Item
    • Duan-Porter, Wei, Karen M. Goldstein, Jennifer McDuffie, Jaime M. Hughes, Megan Clowse, Ruth Klap, Varsha Masilamani, et al. “MAPPING THE EVIDENCE: INTERVENTION SEX EFFECTS FOR DEPRESSION, DIABETES, AND CHRONIC PAIN.” In Journal of General Internal Medicine, 31:S296–97. SPRINGER, 2016.
       Link to Item
    • Pokorney, Sean, Debbie C. Yen, Kristen Campbell, Nancy Allen LaPointe, and Sana Al-Khatib. “RECONSIDERING APPROPRIATE DOFETILIDE DOSING IN WOMEN.” In Journal of the American College of Cardiology, 65:A382–A382. Elsevier BV, 2015. https://doi.org/10.1016/s0735-1097(15)60382-5.
       Full Text
    • Kramer, J. M., A. Y. Chen, B. G. Hammill, E. R. DeLong, N. A. LaPointe, L. H. Muhlbaier, C. B. McCants, and R. M. Califf. “Time trends and factors associated with outpatient beta-blocker use in patients with heart failure or left ventricular dysfunction.” In Circulation, 109:E265–E265. LIPPINCOTT WILLIAMS & WILKINS, 2004.
       Link to Item
    • Kramer, J. M., D. Fetterolf, J. P. Charde, R. Snyder, B. Hammill, E. DeLong, B. S. Hoffman, R. L. Arrington, N. A. LaPointe, and E. D. Peterson. “National evaluation of adherence to beta-blocker therapy for one year after acute myocardial infarction in patients with commercial health insurance.” In Circulation, 109:E289–E289. LIPPINCOTT WILLIAMS & WILKINS, 2004.
       Link to Item
    • Al-Khatib, Sana M., Nancy M. Allen LaPointe, Judith M. Kramer, Anita Y. Chen, Bradley G. Hammill, Liz DeLong, and Robert M. Califf. “1096-71 A national survey of health care practitioners' knowledge of the QT interval.” In Journal of the American College of Cardiology, 43:A408–A408. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91724-x.
       Full Text
    • Kramer, Judith M., Donald Fetterolf, John P. Charde, Richard Snyder, Daniel Checkman, Elizabeth DeLong, Nancy Allen LaPointe, Barbara Hoffman, Rhonda L. Arrington, and Eric Peterson. “838-4 National evaluation of long-term adherence to beta-blocker therapy after acute myocardial infarction in patients with commercial health insurance.” In Journal of the American College of Cardiology, 43:A415–16. Elsevier BV, 2004. https://doi.org/10.1016/s0735-1097(04)91753-6.
       Full Text
    • Cowper, P. A., E. R. Delong, D. J. Whellan, N. A. Lapointe, and R. M. Califf. “Economic impact of beta-blocker therapy in patients with congestive heart failure.” In Circulation, 106:E106–E106. LIPPINCOTT WILLIAMS & WILKINS, 2002.
       Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.